Posted On: 01/30/2015 5:12:25 PM
Post# of 5066
Another question(s) as an open IND gets closer and closer.
Would the company be in the position to be in international studies after approval?
Would the company have strong intentions to run parallel studies with the INDs? I ask this as so many indications have been mentioned within each IND, and most recently, using these therapies all-together synergistically.
Would the company be in the position to be in international studies after approval?
Would the company have strong intentions to run parallel studies with the INDs? I ask this as so many indications have been mentioned within each IND, and most recently, using these therapies all-together synergistically.
(0)
(0)
